Aligos Amends ESPP to Increase Share Availability
Aligos Therapeutics amended its 2020 Employee Stock Purchase Plan to increase the maximum share issuance to 694,714 shares. This action requires stockholder approval and is intended to support the company's equitable compensation programs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day